AIM
HZNP

Allstate Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Allstate Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$715K Buy
+6,282
New +$522K 0.02% 422

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Allstate Investment Management's HZNP Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022: 6,282 shares worth $715K. The stake represents 0.02% of the portfolio and ranks #422 among its holdings.

615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Allstate Investment Management held 6,282 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $715K as of Q4 2022.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Allstate Investment Management position in Q4 2022.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.02% of Allstate Investment Management's portfolio in Q4 2022, its #422 holding.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.